JPM European Media Internet 2019 Outlook_watermark
.pdfvk.com/id446425943
Daniel Kerven |
Europe Equity Research |
(44-20) 7134-3057 |
10 December 2018 |
daniel kerven@jpmorgan.com |
|
TF1: Summary of Financials
Income Statement |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
|
Cash Flow Statement |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
Revenue |
2,063 |
2,125 |
2,249 |
2,296 |
2,319 |
|
Cash flow from operating activities |
229 |
269 |
326 |
202 |
203 |
COGS |
- |
- |
- |
- |
- |
|
o/w Depreciation & amortization |
178 |
173 |
220 |
63 |
64 |
Gross profit |
- |
- |
- |
- |
- |
|
o/w Changes in working capital |
15 |
(82) |
0 |
(5) |
(5) |
SG&A |
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
Adj. EBITDA |
307 |
359 |
407 |
265 |
276 |
|
Cash flow from investing activities |
(316) |
(150) |
(428) |
(64) |
(65) |
D&A |
(178) |
(173) |
(220) |
(63) |
(64) |
|
o/w Capital expenditure |
(205) |
(189) |
(63) |
(64) |
(65) |
Adj. EBIT |
129 |
185 |
187 |
202 |
212 |
|
as % of sales |
9.9% |
8.9% |
2.8% |
2.8% |
2.8% |
Net Interest |
(84) |
(23) |
(25) |
0 |
0 |
|
|
|
|
|
|
|
Adj. PBT |
41 |
168 |
162 |
202 |
212 |
|
Cash flow from financing activities |
(195) |
(43) |
(79) |
(124) |
(81) |
Tax |
(6) |
(45) |
(55) |
(57) |
(67) |
|
o/w Dividends paid |
(167) |
(59) |
(73) |
(69) |
(76) |
Minority Interest |
(2) |
(0) |
(0) |
(0) |
(0) |
|
o/w Shares issued/(repurchased) |
(20) |
0 |
0 |
(50) |
0 |
Adj. Net Income |
125 |
159 |
128 |
140 |
141 |
|
o/w Net debt issued/(repaid) |
(6) |
17 |
0 |
0 |
0 |
Reported EPS |
0.20 |
0.65 |
0.49 |
0.68 |
0.69 |
|
Net change in cash |
(282) |
76 |
(180) |
14 |
57 |
Adj. EPS |
0.60 |
0.76 |
0.61 |
0.68 |
0.69 |
|
|
24 |
255 |
263 |
138 |
137 |
DPS |
0.28 |
0.35 |
0.33 |
0.37 |
0.37 |
|
Adj. Free cash flow to firm |
|||||
|
y/y Growth |
(70.6%) |
986.4% |
3.1% |
(47.6%) |
(0.3%) |
||||||
Payout ratio |
141.0% |
54.1% |
67.6% |
54.1% |
54.1% |
|
|
|
|
|
|
|
Shares outstanding |
210 |
211 |
210 |
207 |
204 |
|
|
|
|
|
|
|
Balance Sheet |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
|
Ratio Analysis |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
Cash and cash equivalents |
420 |
496 |
316 |
329 |
386 |
|
Gross margin |
- |
- |
- |
- |
- |
Accounts receivable |
980 |
1,205 |
1,205 |
1,205 |
1,205 |
|
EBITDA margin |
14 9% |
16 9% |
18.1% |
11 5% |
11.9% |
Inventories |
678 |
616 |
616 |
621 |
626 |
|
EBIT margin |
6 3% |
8.7% |
8.3% |
8.8% |
9.1% |
Other current assets |
45 |
13 |
378 |
378 |
378 |
|
Net profit margin |
6.1% |
7.5% |
5.7% |
6.1% |
6.1% |
Current assets |
2,123 |
2,329 |
2,514 |
2,533 |
2,594 |
|
Organic Revenue growth |
- |
- |
- |
- |
- |
PP&E |
1,093 |
1,061 |
911 |
919 |
927 |
|
Net debt/EBITDA |
(60.8%) |
(71.6%) |
(18.8%) |
(34.0%) |
(53.2%) |
LT investments |
|
|
|
|
- |
|
|
|
|
|
|
|
Other non current assets |
0 |
0 |
0 |
0 |
0 |
|
Sales/Assets (x) |
0.6 |
0.6 |
0.7 |
0.7 |
0.7 |
Total assets |
3,216 |
3,390 |
3,425 |
3,452 |
3,522 |
|
Assets/Equity (x) |
2.0 |
2.1 |
2.1 |
2.1 |
2.1 |
|
|
|
|
|
|
|
Interest cover (x) |
3.7 |
15.4 |
16.0 |
- |
- |
|
|
|
|
|
|
|
||||||
Short term borrowings |
|
|
|
|
- |
|
Tax rate |
14 3% |
26 5% |
33.8% |
28 3% |
31.6% |
Payables |
1,368 |
1,466 |
1,466 |
1,466 |
1,466 |
|
|
|
|
|
|
|
Other short term liabilities |
0 |
0 |
0 |
0 |
0 |
|
Revenue y/y Growth |
2 9% |
3.0% |
5.9% |
2.1% |
1.0% |
Current liabilities |
1,368 |
1,466 |
1,466 |
1,466 |
1,466 |
|
EBITDA y/y Growth |
43.1% |
16.8% |
13 5% |
(34.9%) |
4.1% |
Long-term debt |
234 |
239 |
239 |
239 |
239 |
|
EPS y/y Growth |
8.4% |
26.8% |
(19.5%) |
11 2% |
1.7% |
Other long term liabilities |
122 |
103 |
108 |
113 |
118 |
|
|
|
|
|
|
|
Total liabilities |
1,723 |
1,809 |
1,814 |
1,819 |
1,824 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Valuation |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
Shareholders' equity |
1,493 |
1,582 |
1,611 |
1,633 |
1,698 |
|
P/E (x) |
12.7 |
10.0 |
12.4 |
11.2 |
11.0 |
Minority interests |
|
|
|
|
- |
|
FCFE Yield |
1.4% |
15 9% |
16 2% |
8.5% |
8.6% |
Total liabilities & equity |
3,216 |
3,390 |
3,425 |
3,452 |
3,522 |
|
EV/EBITDA (x) |
4.9 |
4.0 |
3.3 |
5.0 |
4.6 |
|
|
|
|
|
|
|
Dividend Yield |
3.7% |
4.6% |
4.4% |
4.8% |
4.9% |
Net debt/(cash) |
(187) |
(257) |
(76) |
(90) |
(147) |
|
||||||
|
|
|
|
|
|
|
Source: Company reports and J.P. Morgan estimates.
Note: € in millions (except per-share data).Fiscal year ends Dec. o/w - out of which
71
vk.com/id446425943
Daniel Kerven (44-20) 7134-3057
daniel kerven@jpmorgan.com
Overweight
Company Data
Price (€) |
68.16 |
Date Of Price |
07 Dec 18 |
Price Target (€) |
120.00 |
Price Target End Date |
31-Mar-19 |
52-week Range (€) |
107.90-61.28 |
Market Cap (€ bn) |
7.61 |
Shares O/S (mn) |
112 |
Ubisoft: DCF
€ million, Mar-YE
Wacc (%) |
9.0% |
G |
3.0% |
Present Value of FCF (18-30) |
5,384 |
Present Value of Terminal Value |
8,865 |
Enterprise Value |
14,249 |
(Net Debt)/Net Cash |
-147 |
Equity Value |
14,102 |
Outstanding Shares (bl) |
117.7 |
Equity value per Share (€) |
120 |
Source: J.P. Morgan estimates.
Europe Equity Research
10 December 2018
Ubisoft
Ubisoft Entertainment SA (UBIP.PA;UBI FP)
FYE Mar |
2018A |
2019E |
2019E |
2020E |
2020E |
|
|
(Prev) |
(Curr) |
(Prev) |
(Curr) |
Adj. EPS FY (€) |
1.80 |
3.17 |
3.17 |
4.11 |
3.95 |
Revenue FY (€ mn) |
1,732 |
2,187 |
2,185 |
2,531 |
2,473 |
EBITDA FY (€ mn) |
844 |
1,077 |
1,076 |
1,276 |
1,247 |
EBITDA Margin FY |
48.7% |
49.3% |
49.2% |
50.4% |
50.4% |
EBIT FY (€ mn) |
300 |
500 |
500 |
634 |
610 |
EBIT Margin FY |
17.3% |
22.9% |
22.9% |
25.1% |
24.7% |
Net Income adjusted FY (€ |
220 |
376 |
376 |
480 |
461 |
mn) |
|
|
|
|
|
Adjusted P/E FY |
37.9 |
21.5 |
21.5 |
16.6 |
17.3 |
Source: Company data, Bloomberg, J.P. Morgan estimates.
Investment Thesis, Valuation and Risks Ubisoft (Overweight; Price Target: €120.00)
Investment Thesis
In our view, near-term multiples do not reflect medium-term growth and margin expansion and the improving visibility and quality of earnings. UBI trades on a Mar-20 PE of 16.7x falling to 11x in 2022. It trades on 20.5x Mar-20 EV/NOPAT. We see potential upside from one or more of Ubisoft’s games breaking into the major league of 15-20m titles, from China, cloud based services and subscription bundles. We think it’s not “too late” to buy into the Ubisoft story, and we remain OW.
Valuation
Our 2019E estimates remain unchanged as we believe company guidance is conservative. We have slightly reduced our 2020E / 21E EPS by c3% / 5.5% on more conservative assumptions for Player Recurring Investment in case of macro slowdown / contraction. Our DCF based valuation decreases from €130 to €120 with a WACC of 9.0% and terminal growth of 3%.
Risks to Rating and Price Target
Risks include 1) unexpected delays of games; 2) weaker-than-expected next generation console sales; 3) FX changes; 4) higher-than-expected cash research and development costs; 5) negative reviews of blockbuster games; and 6) worse-than- expected monetisation of key franchises via additional content and other revenues (including movies).
72
vk.com/id446425943
Daniel Kerven |
Europe Equity Research |
(44-20) 7134-3057 |
10 December 2018 |
daniel kerven@jpmorgan.com |
|
Ubisoft: Summary of Financials
Income Statement |
FY17A FY18A FY19E FY20E FY21E |
||||
Revenue |
1,460 |
1,732 |
2,185 |
2,473 |
2,958 |
COGS |
(271) |
(297) |
(341) |
(357) |
(404) |
Gross profit |
- |
- |
- |
- |
- |
SG&A |
(477) |
(591) |
(769) |
(869) |
(1,060) |
Adj. EBITDA |
712 |
844 |
1,076 |
1,247 |
1,494 |
D&A |
(475) |
(544) |
(576) |
(637) |
(700) |
Adj. EBIT |
238 |
300 |
500 |
610 |
794 |
Net Interest |
(7) |
(8) |
64 |
(11) |
(10) |
Cash Flow Statement |
FY17A |
FY18A |
FY19E |
FY20E |
FY21E |
Cash flow from operating activities |
149 |
170 |
436 |
508 |
683 |
o/w Depreciation & amortization |
475 |
544 |
576 |
637 |
700 |
o/w Changes in working capital |
39 |
(45) |
(50) |
(20) |
(20) |
|
(169) |
(239) |
(80) |
(87) |
(93) |
Cash flow from investing activities |
|||||
o/w Capital expenditure |
(63) |
(59) |
(80) |
(87) |
(93) |
as % of sales |
4.3% |
3.4% |
3.7% |
3.5% |
3.2% |
|
|
|
|
|
|
Adj. PBT |
228 |
294 |
488 |
599 |
784 |
Tax |
(51) |
(69) |
(117) |
(124) |
(166) |
Minority Interest |
- |
- |
- |
- |
- |
Adj. Net Income |
174 |
220 |
376 |
461 |
604 |
Reported EPS |
0.98 |
1.19 |
3.30 |
3 56 |
4.89 |
Adj. EPS |
1.45 |
1.80 |
3.17 |
3.95 |
5.32 |
Cash flow from financing activities |
397 |
48 |
45 |
(351) |
(495) |
o/w Dividends paid |
0 |
0 |
0 |
0 |
0 |
o/w Shares issued/(repurchased) |
(68) |
(411) |
0 |
(292) |
(432) |
o/w Net debt issued/(repaid) |
454 |
407 |
0 |
0 |
0 |
Net change in cash |
370 |
(21) |
373 |
70 |
95 |
|
|
|
|
|
|
DPS |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
Adj. Free cash flow to firm |
93 |
118 |
341 |
432 |
600 |
|
y/y Growth |
(149.7%) |
26.5% |
188.8% |
26.5% |
38.9% |
||||||
Payout ratio |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
|
|
|
|
|
|
|
Shares outstanding |
120 |
122 |
119 |
117 |
114 |
|
|
|
|
|
|
|
Balance Sheet |
FY17A |
FY18A |
FY19E |
FY20E |
FY21E |
|
Ratio Analysis |
FY17A |
FY18A |
FY19E |
FY20E |
FY21E |
Cash and cash equivalents |
853 |
747 |
1,148 |
1,218 |
1,313 |
|
Gross margin |
- |
- |
- |
- |
- |
Accounts receivable |
|
|
|
|
|
|
EBITDA margin |
48.8% |
48.7% |
49.2% |
50.4% |
50.5% |
Inventories |
|
|
|
|
|
|
EBIT margin |
16.3% |
17 3% |
22.9% |
24.7% |
26.9% |
Other current assets |
611 |
711 |
749 |
758 |
768 |
|
Net profit margin |
11.9% |
12.7% |
17.2% |
18.7% |
20.4% |
Current assets |
1,464 |
1,458 |
1,897 |
1,976 |
2,081 |
|
Organic Revenue growth |
- |
- |
- |
- |
- |
PP&E |
|
|
|
|
|
|
Net debt/EBITDA |
0.1 |
0.6 |
0.1 |
0.1 |
(0.0) |
LT investments |
|
|
|
|
|
|
|
|
|
|
|
|
Other non current assets |
1,118 |
1,347 |
1,388 |
1,422 |
1,430 |
|
Sales/Assets (x) |
0.6 |
0.6 |
0.7 |
0.7 |
0.9 |
Total assets |
2,582 |
2,805 |
3,285 |
3,398 |
3,511 |
|
Assets/Equity (x) |
2.1 |
2.7 |
2.8 |
2.5 |
2.4 |
|
|
|
|
|
|
|
Interest cover (x) |
98.9 |
109.6 |
- |
114.8 |
147.7 |
|
|
|
|
|
|
|
||||||
Short term borrowings |
|
|
|
|
|
|
Tax rate |
23.7% |
25.0% |
23.0% |
23.0% |
23.0% |
Payables |
398 |
499 |
499 |
499 |
499 |
|
|
|
|
|
|
|
Other short term liabilities |
0 |
0 |
0 |
0 |
0 |
|
Revenue y/y Growth |
4.7% |
18.6% |
26.2% |
13.2% |
19.6% |
Current liabilities |
398 |
499 |
499 |
499 |
499 |
|
EBITDA y/y Growth |
12.8% |
18 5% |
27.5% |
15.9% |
19.8% |
Long-term debt |
934 |
1,295 |
1,295 |
1,295 |
1,295 |
|
EPS y/y Growth |
28.9% |
23.7% |
76.0% |
24.6% |
34.7% |
Other long term liabilities |
116 |
122 |
210 |
199 |
189 |
|
|
|
|
|
|
|
Total liabilities |
1,448 |
1,916 |
2,004 |
1,993 |
1,983 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Valuation |
FY17A FY18A FY19E FY20E FY21E |
||||
Shareholders' equity |
1,134 |
889 |
1,281 |
1,405 |
1,528 |
|
P/E (x) |
46.9 |
37.9 |
21 5 |
17.3 |
12.8 |
Minority interests |
- |
- |
- |
- |
- |
|
FCFE Yield |
- |
- |
- |
- |
- |
Total liabilities & equity |
2,582 |
2,805 |
3,285 |
3,398 |
3,511 |
|
EV/EBITDA (x) |
10.9 |
9.7 |
7 3 |
6.2 |
5.1 |
|
|
|
|
|
|
|
Dividend Yield |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
Net debt/(cash) |
81 |
548 |
147 |
77 |
(18) |
|
||||||
|
|
|
|
|
|
|
Source: Company reports and J P. Morgan estimates.
Note: € in millions (except per-share data).Fiscal year ends Mar. o/w - out of which
73
vk.com/id446425943
Daniel Kerven |
Europe Equity Research |
(44-20) 7134-3057 |
10 December 2018 |
daniel kerven@jpmorgan.com |
|
Overweight
Company Data
Price (€) |
21.25 |
Date Of Price |
07 Dec 18 |
Price Target (€) |
40.00 |
Price Target End Date |
31-Dec-19 |
52-week Range (€) |
24.87-20.26 |
Market Cap (€ bn) |
26.70 |
Shares O/S (mn) |
1,257 |
Vivendi
Vivendi (VIV.PA;VIV FP)
FYE Dec |
2017A |
2018E |
2019E |
2019E |
|
|
|
(Prev) |
(Curr) |
Adj. EPS FY (€) |
1.05 |
0.86 |
1.12 |
1.10 |
Bloomberg EPS FY (€) |
0.75 |
0.88 |
- |
1.05 |
Adj P/E FY |
20.3 |
24.7 |
19.0 |
19.2 |
Group org. growth FY |
4.1% |
2.8% |
5.1% |
5.0% |
Revenue FY (€ mn) |
12,501 |
13,689 |
14,546 |
14,540 |
Adj. EBITA FY (€ mn) |
987 |
1,289 |
1,610 |
1,587 |
DPS (Net) FY (€) |
0.45 |
0.43 |
0.56 |
0.55 |
Net Debt/EBITDA FY |
2.0 |
0.1 |
(0.1) |
(0.1) |
Source: Company data, Bloomberg, J.P. Morgan estimates.
Investment Thesis, Valuation and Risks Vivendi (Overweight; Price Target: €40.00)
Investment Thesis
Vivendi is one of the best ways to get exposure to Music, which in our view offers the best content story in media. We believe Universal Music more than underpins Vivendi’s entire EV and has the potential to drive multiples of upside as subscriptions become the global norm, driving revenue growth, margin expansion, improved earnings visibility and a re-rating. Vivendi’s other activities have been a drag on earnings and sentiment – however, expectations and valuations for these activities are now low and they could become a source of upside should momentum improve.
Valuation
Our Dec-19 SOTP-based valuation decrease from €42 to €40. We value UMG at €43.3bn, we have a C+ group valuation of €3.6bn (down from €3.9bn) and we mark to market its listed investments. Please see our deep dive note on Vivendi (link).
Vivendi SOTP
|
Stake |
EV/EBITDA |
|
|
EV/NOPAT |
Value |
€ million, year-end 31 December |
% |
2018E |
2019E |
2018E |
2019E |
€m |
UMG |
100% |
46.9 |
38.0 |
66.4 |
53.2 |
43,332 |
C+ Group |
|
5.7 |
5.4 |
14.0 |
13.4 |
3,631 |
Havas |
|
8.9 |
8.0 |
16.1 |
14.2 |
2,509 |
Gameloft |
|
28.2 |
19.3 |
304.2 |
78.1 |
237 |
Village |
|
5.9 |
3.8 |
-16.0 |
-17.4 |
88 |
New Initiatives |
|
-0.8 |
-2.2 |
-0.9 |
-1.5 |
50 |
Corporate |
|
9.8 |
9.8 |
14.8 |
14.8 |
-1,077 |
EV |
|
28.8 |
24.0 |
28.0 |
22.8 |
48,771 |
Value of stakes |
|
|
|
|
|
4,023 |
Tax assets |
|
|
|
|
|
626 |
Pension and other provisions |
|
|
|
|
|
-1,807 |
Less net Debt |
|
|
|
|
|
-636 |
Mediaset settlement |
|
|
|
|
|
-500 |
Equity Value |
|
|
|
|
|
50,477 |
No Shares |
|
|
|
|
|
1,257 |
Value per share (€) |
|
|
|
|
|
40 |
Source: J.P. Morgan estimates.
Risks to Rating and Price Target
The following risks could prevent the stock from achieving our target price and rating: 1) worse-than-expected operating performance at Canal+ Group and UMG; 2) valueilutive acquisitions; and 3) lower-than-expected cash return to shareholders.
74
vk.com/id446425943
Daniel Kerven |
Europe Equity Research |
(44-20) 7134-3057 |
10 December 2018 |
daniel kerven@jpmorgan.com |
|
Vivendi: Summary of Financials
Income Statement |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
|
Cash Flow Statement |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
Revenue |
10,819 |
12,501 |
13,689 |
14,540 |
15,396 |
|
Cash flow from operating activities |
696 |
960 |
1,159 |
1,493 |
1,814 |
COGS |
|
|
|
|
- |
|
o/w Depreciation & amortization |
309 |
337 |
405 |
448 |
463 |
Gross profit |
|
|
|
|
- |
|
o/w Changes in working capital |
(7) |
247 |
(20) |
(20) |
(20) |
SG&A |
|
|
|
|
- |
|
|
|
|
|
|
|
Adj. EBITDA |
1,033 |
1,324 |
1,694 |
2,034 |
2,361 |
|
Cash flow from investing activities |
(2,401) |
(3,283) |
1,785 |
(506) |
(528) |
D&A |
(309) |
(337) |
(405) |
(448) |
(463) |
|
o/w Capital expenditure |
(233) |
(259) |
(285) |
(294) |
(303) |
Adj. EBIT |
724 |
987 |
1,289 |
1,587 |
1,898 |
|
as % of sales |
2.2% |
2.1% |
2.1% |
2.0% |
2.0% |
Net Interest |
(40) |
(53) |
(56) |
(26) |
(19) |
|
|
|
|
|
|
|
Adj. PBT |
945 |
1,168 |
1,512 |
1,926 |
2,260 |
|
Cash flow from financing activities |
(3,843) |
(2,459) |
(762) |
(664) |
(794) |
Tax |
(162) |
189 |
(395) |
(499) |
(564) |
|
o/w Dividends paid |
(2,555) |
(470) |
(545) |
(447) |
(577) |
Minority Interest |
(28) |
(45) |
(36) |
(38) |
(39) |
|
o/w Shares issued/(repurchased) |
(1,542) |
(51) |
0 |
0 |
0 |
Adj. Net Income |
755 |
1,312 |
1,081 |
1,388 |
1,657 |
|
o/w Net debt issued/(repaid) |
- |
- |
- |
- |
- |
Reported EPS |
0.59 |
1.05 |
0.86 |
1.10 |
1.32 |
|
Net change in cash |
(5,548) |
(4,782) |
2,182 |
323 |
492 |
Adj. EPS |
0.59 |
1.05 |
0.86 |
1.10 |
1.32 |
|
|
381 |
1,399 |
785 |
1,088 |
1,367 |
DPS |
0.40 |
0.45 |
0.43 |
0.55 |
0.66 |
|
Adj. Free cash flow to firm |
|||||
|
y/y Growth |
(1076.9%) |
267.2% |
(43.9%) |
38.6% |
25.7% |
||||||
Payout ratio |
67.6% |
43.0% |
50.0% |
50.0% |
50.0% |
|
|
|
|
|
|
|
Shares outstanding |
1,276 |
1,253 |
1,257 |
1,257 |
1,257 |
|
|
|
|
|
|
|
Balance Sheet |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
|
Ratio Analysis |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
Cash and cash equivalents |
4,072 |
1,951 |
4,079 |
3,900 |
4,554 |
|
Gross margin |
- |
- |
- |
- |
- |
Accounts receivable |
4,011 |
6,754 |
6,804 |
6,839 |
6,859 |
|
EBITDA margin |
9.5% |
10.6% |
12.4% |
14.0% |
15.3% |
Inventories |
|
|
|
|
- |
|
EBIT margin |
6.7% |
7.9% |
9.4% |
10.9% |
12.3% |
Other current assets |
1,077 |
345 |
345 |
345 |
345 |
|
Net profit margin |
7.0% |
10.5% |
7.9% |
9.5% |
10.8% |
Current assets |
9,160 |
9,050 |
11,228 |
11,084 |
11,758 |
|
Organic Revenue growth |
(0.2%) |
4.1% |
2.8% |
5.0% |
5.9% |
PP&E |
23,205 |
25,283 |
22,963 |
22,892 |
22,826 |
|
Net debt/EBITDA |
0.0 |
2.0 |
0.1 |
(0.1) |
(0.4) |
LT investments |
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
Other non current assets |
0 |
0 |
0 |
0 |
0 |
|
Sales/Assets (x) |
0.3 |
0.4 |
0.4 |
0.4 |
0.4 |
Total assets |
32,365 |
34,333 |
34,191 |
33,976 |
34,584 |
|
Assets/Equity (x) |
1.7 |
1.8 |
1.9 |
1 9 |
1.8 |
|
|
|
|
|
|
|
Interest cover (x) |
25.8 |
25.0 |
30.0 |
79.4 |
127 5 |
|
|
|
|
|
|
|
||||||
Short term borrowings |
|
|
|
|
- |
|
Tax rate |
17.1% |
16.2% |
26.1% |
25.9% |
25.0% |
Payables |
5,614 |
9,001 |
9,001 |
9,001 |
9,001 |
|
|
|
|
|
|
|
Other short term liabilities |
0 |
0 |
0 |
0 |
0 |
|
Revenue y/y Growth |
0.5% |
15.5% |
9.5% |
6.2% |
5.9% |
Current liabilities |
5,614 |
9,001 |
9,001 |
9,001 |
9,001 |
|
EBITDA y/y Growth |
(17.2%) |
28.2% |
28.0% |
20.1% |
16.1% |
Long-term debt |
4,081 |
4,636 |
4,331 |
3,631 |
3,631 |
|
EPS y/y Growth |
16.1% |
77.0% |
(17.9%) |
28.4% |
19.4% |
Other long term liabilities |
3,058 |
2,818 |
2,818 |
2,818 |
2,818 |
|
|
|
|
|
|
|
Total liabilities |
12,753 |
16,455 |
16,150 |
15,450 |
15,450 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Valuation |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
Shareholders' equity |
19,383 |
17,656 |
17,819 |
18,304 |
18,912 |
|
P/E (x) |
35.9 |
20 3 |
24.7 |
19 2 |
16.1 |
Minority interests |
229 |
222 |
222 |
222 |
222 |
|
FCFE Yield |
1.3% |
5.1% |
2.7% |
4.0% |
5.0% |
Total liabilities & equity |
32,365 |
34,333 |
34,191 |
33,976 |
34,584 |
|
EV/EBITDA (x) |
26.8 |
22 9 |
16.5 |
13.4 |
11 3 |
|
|
|
|
|
|
|
Dividend Yield |
1.9% |
2.1% |
2.0% |
2.6% |
3.1% |
Net debt/(cash) |
9 |
2,685 |
252 |
(269) |
(923) |
|
||||||
|
|
|
|
|
|
|
Source: Company reports and J.P. Morgan estimates.
Note: € in millions (except per-share data) Fiscal year ends Dec. o/w - out of which
75
vk.com/id446425943
Daniel Kerven (44-20) 7134-3057
daniel kerven@jpmorgan.com
Overweight
Company Data
Price (p) |
816 |
Date Of Price |
07 Dec 18 |
Price Target (p) |
1,090 |
Price Target End Date |
31-Dec-19 |
52-week Range (p) |
1,474-811 |
Market Cap (£ mn) |
10,337.52 |
Shares O/S (mn) |
1,267 |
WPP summary DCF valuation (£m)
£ million,
PV of FCF (18-30, £m) |
6,993 |
PV of Terminal Value (£m) |
8,352 |
Total Enterprise Value (£m) |
15,345 |
(Net Debt) FY18 (£m) |
-4,708 |
Associates |
880 |
Minorities |
-882 |
Tech, data, content inv. |
250 |
Kantar |
2,766 |
Equity Value (£m) |
13,651 |
Fully diluted Shares (m) |
1,252 |
WPP Equity Value per Share (p) |
1,090 |
Source: J.P. Morgan estimates
Europe Equity Research
10 December 2018
WPP PLC
WPP PLC (WPP.L;WPP LN)
FYE Dec |
2017A |
2018E |
2018E |
2019E |
2019E |
|
|
(Prev) |
(Curr) |
(Prev) |
(Curr) |
Dil.Adj.EPS FY (p) |
120.43 |
105.33 |
105.48 |
96.29 |
97.63 |
Adj.P/E FY |
6.8 |
7.7 |
7.7 |
8.5 |
8.4 |
Net Sales FY (£ mn) |
13,140 |
12,753 |
12,769 |
12,624 |
12,775 |
Adj. Ops. Profit FY (£ mn) |
2,154 |
1,932 |
1,934 |
1,782 |
1,805 |
Adjusted PBT FY (£ mn) |
2,092 |
1,841 |
1,844 |
1,689 |
1,711 |
Adjusted Diluted NP FY (£ |
1,536 |
1,336 |
1,338 |
1,215 |
1,232 |
mn) |
|
|
|
|
|
DPS FY (p) |
60.00 |
60.00 |
60.00 |
60.00 |
60.00 |
Dividend Yield FY |
7.4% |
7.4% |
7.4% |
7.4% |
7.4% |
Source: Company data, Bloomberg, J.P. Morgan estimates.
Investment Thesis, Valuation and Risks WPP PLC (Overweight; Price Target: 1,090p)
Forecast changes
We have slightly increased our estimates due to FX changes. Our 2019 / 20 EPS increase by +1.4% / +1.4%.
Investment Thesis
We continue to believe that the slowdown in the Advertising Agency space can be explained by a number of short-term factors, that structural concerns are overstated and that the role of the agency, to help clients optimise their marketing spend across the marketing funnel, remains just as relevant as in the past. In fact, digital advertising spends grows the overall market, allowing agencies to move beyond traditional marketing to drive consideration, intent and purchases. WPP is well placed, in our view, given its scale, geographic reach and expertise across disciplines. With c30% implied upside to our PT, we remain OW.
WPP trades on 8.5x earnings in 2020E for 2020E-23E EPS growth of c7% pa. It offers a 2018E yield of 7.4%. WPP’s peers trade on 11.3x earnings in 2020E and offer a yield of 4%.
Valuation
Our Dec-19 DCF based price target increases from 1,070p to 1,090p as a result of our changes in estimates. Our DCF assumes a WACC of 8.5%, terminal growth of 1.5% and operating margin of 15.2%.
Risks to Rating and Price Target
The following risks could prevent the stock from achieving our target price and rating: 1) worse-than-expected economic and advertising environment (particularly following Brexit); 2) value-destroying acquisitions; 3) costs may increase faster than expected, implying lower-than-expected operating margins; 4) substantial number of client contracts lost due to peer competition on pricing; and 5) increased competition from Consultancy/IT firms could lead to market share loss.
76
vk.com/id446425943
Daniel Kerven |
Europe Equity Research |
(44-20) 7134-3057 |
10 December 2018 |
daniel kerven@jpmorgan.com |
|
WPP PLC: Summary of Financials
Income Statement |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
|
Cash Flow Statement |
FY16A FY17A FY18E FY19E FY20E |
||||
Revenue |
12,398 |
13,140 |
12,769 |
12,775 |
11,011 |
|
Cash flow from operating activities |
1,869 |
1,514 |
1,665 |
1,648 |
1,500 |
COGS |
|
|
|
|
- |
|
o/w Depreciation & amortization |
259 |
267 |
301 |
325 |
327 |
Gross profit |
|
|
|
|
- |
|
o/w Changes in working capital |
(151) |
(532) |
(60) |
(30) |
(26) |
SG&A |
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
Adj. EBITDA |
2,420 |
2,534 |
2,298 |
2,169 |
1,997 |
|
Cash flow from investing activities |
(975) |
(547) |
(600) |
(490) |
(593) |
D&A |
(260) |
(267) |
(274) |
(285) |
(245) |
|
o/w Capital expenditure |
(277) |
(318) |
(350) |
(340) |
(293) |
Adj. EBIT |
2,095 |
2,154 |
1,934 |
1,805 |
1,580 |
|
as % of sales |
2.2% |
2.4% |
2.7% |
2.7% |
2.7% |
Net Interest |
(174) |
(175) |
(180) |
(173) |
(149) |
|
|
|
|
|
|
|
Adj. PBT |
1,986 |
2,092 |
1,844 |
1,711 |
1,602 |
|
Cash flow from financing activities |
(1,468) |
(931) |
(999) |
(1,398) |
(228) |
Tax |
(417) |
(460) |
(415) |
(392) |
(358) |
|
o/w Dividends paid |
(633) |
(776) |
(768) |
(740) |
(721) |
Minority Interest |
(102) |
(96) |
(91) |
(88) |
(88) |
|
o/w Shares issued/(repurchased) |
(427) |
(504) |
(200) |
(150) |
(500) |
Adj. Net Income |
1,467 |
1,536 |
1,338 |
1,232 |
1,156 |
|
o/w Net debt issued/(repaid) |
(23) |
600 |
(300) |
(530) |
(400) |
Reported EPS |
113.19 |
120.43 |
105.48 |
97.63 |
94.75 |
|
Net change in cash |
(573) |
37 |
66 |
(240) |
679 |
Adj. EPS |
113.19 |
120.43 |
105.48 |
97.63 |
94.75 |
|
|
1,575 |
1,172 |
1,299 |
1,316 |
1,209 |
DPS |
56.60 |
60.00 |
60.00 |
60.00 |
60.00 |
|
Adj. Free cash flow to firm |
|||||
|
y/y Growth |
28.8% |
(25.6%) |
10.9% |
1.3% |
(8.2%) |
||||||
Payout ratio |
50.0% |
49.8% |
56.9% |
61.5% |
63 3% |
|
|
|
|
|
|
|
Shares outstanding |
1,296 |
1,276 |
1,268 |
1,261 |
1,220 |
|
|
|
|
|
|
|
Balance Sheet |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
|
Ratio Analysis |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
Cash and cash equivalents |
2,437 |
2,391 |
2,527 |
2,263 |
3,093 |
|
Gross margin |
- |
- |
- |
- |
- |
Accounts receivable |
|
|
|
|
- |
|
EBITDA margin |
19 5% |
19.3% |
18.0% |
17.0% |
18.1% |
Inventories |
|
|
|
|
- |
|
EBIT margin |
17.4% |
17.3% |
15.9% |
14.8% |
15.9% |
Other current assets |
0 |
0 |
0 |
0 |
0 |
|
Net profit margin |
11.8% |
11.7% |
10.5% |
9.6% |
10.5% |
Current assets |
2,437 |
2,391 |
2,527 |
2,263 |
3,093 |
|
Organic Revenue growth |
- |
- |
- |
- |
- |
PP&E |
32,131 |
31,277 |
31,676 |
31,878 |
32,277 |
|
Net debt/EBITDA |
6.5 |
5.7 |
6 5 |
7.1 |
8.2 |
LT investments |
|
|
|
|
- |
|
|
|
|
|
|
|
Other non current assets |
0 |
0 |
0 |
0 |
0 |
|
Sales/Assets (x) |
0.4 |
0.4 |
0.4 |
0.4 |
0.3 |
Total assets |
34,568 |
33,669 |
34,202 |
34,142 |
35,370 |
|
Assets/Equity (x) |
3.7 |
3.6 |
3 5 |
3.5 |
3.5 |
|
|
|
|
|
|
|
Interest cover (x) |
13.9 |
14.5 |
12.7 |
12.5 |
13.4 |
|
|
|
|
|
|
|
||||||
Short term borrowings |
|
|
|
|
- |
|
Tax rate |
21.0% |
22.0% |
22.5% |
22 9% |
22.3% |
Payables |
|
|
|
|
- |
|
|
|
|
|
|
|
Other short term liabilities |
6,567 |
6,875 |
6,575 |
6,045 |
5,645 |
|
Revenue y/y Growth |
17.8% |
6.0% |
(2.8%) |
0.0% |
(13.8%) |
Current liabilities |
6,567 |
6,875 |
6,575 |
6,045 |
5,645 |
|
EBITDA y/y Growth |
20 9% |
4.7% |
(9.3%) |
(5.6%) |
(7.9%) |
Long-term debt |
18,233 |
16,832 |
17,437 |
17,676 |
19,490 |
|
EPS y/y Growth |
20 9% |
6.4% |
(12.4%) |
(7.4%) |
(3.0%) |
Other long term liabilities |
0 |
0 |
0 |
0 |
0 |
|
|
|
|
|
|
|
Total liabilities |
24,801 |
23,707 |
24,012 |
23,721 |
25,134 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Valuation |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
Shareholders' equity |
9,325 |
9,493 |
9,698 |
9,903 |
9,692 |
|
P/E (x) |
7.2 |
6.8 |
7.7 |
8.4 |
8.6 |
Minority interests |
443 |
469 |
493 |
517 |
544 |
|
FCFE Yield |
13 3% |
9.6% |
10.8% |
11.1% |
10.6% |
Total liabilities & equity |
34,568 |
33,669 |
34,202 |
34,142 |
35,370 |
|
EV/EBITDA (x) |
6.8 |
6.5 |
7 2 |
7.1 |
6.5 |
|
|
|
|
|
|
|
Dividend Yield |
6 9% |
7.4% |
7.4% |
7.4% |
7.4% |
Net debt/(cash) |
15,796 |
14,441 |
14,911 |
15,413 |
16,397 |
|
||||||
|
|
|
|
|
|
|
Source: Company reports and J.P. Morgan estimates.
Note: £ in millions (except per-share data).Fiscal year ends Dec. o/w - out of which
77